Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Bionor Pharma reports on Vacc-4x/Endocine study

May 11, 2012

IAVI, GMI and G&D partner to develop novel AIDS vaccine

May 11, 2012

Scientists in Japan present new agents active against drug-resistant HIV-1

May 2, 2012

Scientists in Europe uncover new recognition factor for HIV-1 entry

April 27, 2012

DFH Pharma and NIH collaborate on development of HIV drugs

April 18, 2012

New potential therapies for HIV infection reported by Roche

April 13, 2012

Bristol-Myers Squibb presents novel HIV integrase inhibitors

April 10, 2012

Shionogi-ViiV Healthcare reports initial data from phase III dolutegravir trial

April 3, 2012

FDA approves line extension for etravirine

March 29, 2012

Sangamo cell therapy increases CD4+ T-cell counts in patients with HIV

March 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
$Silhouette of head and brainwith fractal art$
ATAI-dyed Lilly tees up in psychedelics, finds $3.8B fit
BioWorld
Rumblings that psychedelic treatments would soon be ready for prime time gained credence aplenty, and shares of Ataibeckley Inc. (NASDAQ:ATAI) ended July 16 at...